IDiyas

For the Inventor, By the Inventor

Dexheim, Germany

Hartmut Hanauske-Abel

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 73(Granted Patents)


Company Filing History:

goldMedal11 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1988-1997

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5672614 - Pharmaceutical use of pyridine-2,4- and -2,5-dicarboxylic acid amides (1997-09-30),
2. 5512586 - Medicaments based on pyridine-2,4- and 2,5-dicarboxylic acid amides (1996-04-30),
3. 5356909 - Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof (1994-10-18),
4. 5238948 - Pyridine-2,4- and -2,5-dicarboxylic acid derivatives and medicaments (1993-08-24),
5. 5153208 - Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal (1992-10-06),
6. 5143926 - Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use (1992-09-01),
7. 5037839 - Pyridine-2,4-and -2,5-dicarboxylic acid amides and medicaments based on (1991-08-06),
8. 5004748 - Substituted pyridine-2,4-dicarboxylic acid derivatives and medicaments (1991-04-02),
9. 4968670 - Pyridine-2,4- and 2,5-dicarboxylic acid derivatives, a process for their (1990-11-06),
10. 4797471 - Peptide derivatives having an inhibitory action on hydroxylating (1989-01-10),
11. 4717727 - Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the (1988-01-05),

Title: Hartmut Hanauske-Abel: Innovator in Pharmaceutical Chemistry

Introduction

Hartmut Hanauske-Abel is a distinguished inventor based in Dexheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work primarily focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Hanauske-Abel has developed pharmaceutical uses for pyridine-2,4- and -2,5-dicarboxylic acid amides. These inventions relate to derivatives of pyridine-2,4- and -2,5-dicarboxylic acid, which are designed to influence the metabolism of collagen and collagen-like substances. The compounds are also aimed at impacting the biosynthesis of Cl.q. His work in this area has the potential to lead to new medicaments that can significantly improve health outcomes.

Career Highlights

Hanauske-Abel has had a notable career at Hoechst Aktiengesellschaft, where he has been instrumental in advancing pharmaceutical research. His innovative approach and dedication to his work have earned him recognition in the scientific community. His patents reflect a commitment to developing effective treatments that address complex medical issues.

Collaborations

Throughout his career, Hanauske-Abel has collaborated with esteemed colleagues, including Volkmar Gunzler and Dietrich Brocks. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Hartmut Hanauske-Abel's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…